scholarly journals Remote migration of breast filler to the inguinal area: a case report

2021 ◽  
Vol 27 (4) ◽  
pp. 149-152
Author(s):  
Jangyoun Choi ◽  
Ye Sol Kim ◽  
Deuk Young Oh

Polyacrylamide hydrogel (PAAG) is an injectable material for breast augmentation that was developed in the 1980s. It was widely used until the 2000s, but subsequently lost its popularity due to high complication rates. In this case report, we share our experience of a patient complaining of hard and asymmetric breasts who had received PAAG injections 7 years ago. Surprisingly, we found that the filler in the left breast had migrated to the left inguinal area. Although breast fillers have lost ground in recent years, we think that long-term complications of fillers, as observed in this case, will still arise in the future. Therefore, young plastic surgeons who do not have direct experience with this material should be aware of its possible complications.

2009 ◽  
Vol 17 (3) ◽  
pp. 89-96 ◽  
Author(s):  
Walter Peters ◽  
Victor Fornasier

Fewer surgical procedures have a history as fascinating and as terrifying as breast augmentation. Initial efforts at augmentation involved injection of substances such as paraffin or oil into the breast tissue, or the implantation of substances including ivory or glass balls, or rubber. More recent efforts have included the injection of liquid silicone or polyacrylamide hydrogel. The current paper reviews four distinct eras of breast augmentation, and provides the current status of these injection materials. A case report is presented on a woman whose breasts were injected with polyacrylamide hydrogel in Iran. The current status of this group of materials is also presented. During the past 110 years, history has repeated itself during each of the four eras of injection.


Breast Care ◽  
2019 ◽  
Vol 15 (1) ◽  
pp. 38-44
Author(s):  
Ying Yang ◽  
Shumo Li ◽  
Jia He ◽  
Xian Zhao ◽  
Wei Chen ◽  
...  

Background: Although polyacrylamide hydrogel (PAAG) injection for breast augmentation has been prohibited for many years, the long-term complications will be significant for a long period. Few research articles have focused on the clinicopathological analysis. Materials and Methods: We summarized clinical and pathological features of 90 cases after PAAG-injected breast augmentation, including 2 cases of breast cancer developed following PAAG injection. Results: All patients were females between the ages of 30 and 64 years (mean, 44 years). The complications included masses (75.58%), pain (45.35%), migration (22.09%), deformation (18.60%), infection (16.28%), induration (4.65%), and psychological fear (2.33%). Microscopically, the PAAG presented as purple gel pools, and the foreign body reaction was noted in all 90 patients. The proportion of fibrous component exceeded 90% in 26 cases (28.89%). Chronic and acute inflammation was noted in 70 (77.78%) and 9 (10%) patients, respectively. The mammary gland around the gel displayed atrophy in 18 cases (20.00%), adenosis in 33 cases (36.67%), ductal carcinoma in situ in 1 case (1.11%), and invasive carcinoma in 1 case (1.11%). Conclusion: The long-term complications of PAAG-injected breast augmentation are various and complex. Pathologically, these complications are associated with foreign body reaction, fibrosis, and inflammation.


Breast Care ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. 273-275 ◽  
Author(s):  
Jinfang Wu ◽  
Xudong Zhang ◽  
Qiming Zhao ◽  
Dongsheng Mao ◽  
Xin Lu

1995 ◽  
Vol 81 (2) ◽  
pp. 148-150
Author(s):  
Emanuele Galante ◽  
Elisabetta Angelini ◽  
Claudio Ferroni ◽  
Paola Scavina ◽  
Sergio Bianchi ◽  
...  

We herein report a case of “multiple neuroendrocine carcinoma” onset, with a torpid course, metastasis in the left breast, and an initial considerable sensitivity to the chemotherapy. We conclude that a re-evaluation of the studies on this neoplasia carried out to date is needed, in order to identify new regimens, which increase the complete response rates and their duration.


2019 ◽  
Author(s):  
BA Högerle ◽  
EL Bulut ◽  
L Klotz ◽  
F Eichhorn ◽  
M Eichhorn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document